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A B S T R A C T
Aim: To investigate lower limb biomechanical strategy during stair walking in patients with diabetes
and patients with diabetic peripheral neuropathy, a population known to exhibit lower limb muscular
weakness.
Methods: The peak lower limb joint moments of twenty-two patients with diabetic peripheral
neuropathy and thirty-nine patients with diabetes and no neuropathy were compared during ascent and
descent of a staircase to thirty-two healthy controls. Fifty-nine of the ninety-four participants also
performed assessment of their maximum isokinetic ankle and knee joint moment (muscle strength) to
assess the level of peak joint moments during the stair task relative to their maximal joint moment-
generating capabilities (operating strengths).
Results: Both patient groups ascended and descended stairs slower than controls (p < 0.05). Peak joint
moments in patients with diabetic peripheral neuropathy were lower (p < 0.05) at the ankle and knee
during stair ascent, and knee only during stair descent compared to controls. Ankle and knee muscle
strength values were lower (p < 0.05) in patients with diabetic peripheral neuropathy compared to
controls, and lower at knee only in patients without neuropathy. Operating strengths were higher
(p < 0.05) at the ankle and knee in patients with neuropathy during stair descent compared to the
controls, but not during stair ascent.
Conclusion: Patients with diabetic peripheral neuropathy walk slower to alter gait strategy during stair
walking and account for lower-limb muscular weakness, but still exhibit heightened operating strengths
during stair descent, which may impact upon fatigue and the ability to recover a safe stance following
postural instability.
 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Contents lists available at ScienceDirect
Gait & Posture
jo u rn al h om ep age: ww w.els evier .c o m/lo c ate /g ai tp os t1. Introduction
Diabetes and associated comorbidities have been shown to
negatively impact upon locomotion: affecting both gait and
balance [1,2]. Diabetic peripheral neuropathy is one of the most
common comorbidities known to inﬂuence gait [3–5], with
diminished foot sensation and progressive muscle weakness
placing individuals at a higher risk of falls than their non-
neuropathic counterparts [6–8].* Corresponding author at: School of Healthcare Science, Faculty of Science and
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4.0/).Previous studies have investigated the kinetics and kinematics
of walking on level ground in patients with diabetes, demonstrat-
ing alterations such as smaller step lengths, lower gait speeds
[9,10] and lower peak joint moments [11,12] than non-diabetic
controls. These gait alterations have been shown to be modulated
by the difﬁculty of the task, with greater effects when walking on
uneven surfaces [13]. Our understanding of how people with
diabetes negotiate stairs is currently very sparse, despite the
higher muscular demands of this task compared to level walking
[14,15] and high risk of falling during stair negotiation
[16,17]. Picon et al. [18] reported lower ankle and knee joint
moments when stepping from stairs to ﬂoor, however this
transitional step whilst more challenging than level walking,
requires lower joint ranges of motion than a step both preceded
and followed by an additional step down, which may result ine under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
Fig. 1. Experimental seven-step staircase with four Kistler force plates built into
steps 2–5. A moveable dolly mounted on the ceiling above the staircase allowed a
safety harness to be used whilst participants walked along the staircase.
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joint moment strategy of negotiating continuous stairs in patients
with diabetes remains unknown. Rate of joint moment production
during stair ascent and descent, has been investigated and patients
with diabetic peripheral neuropathy were shown to generate joint
moments upon initial contact slower, in both stair ascent and
descent [19]. Whilst a slower rate of joint moment production has
been associated with impaired balance [20], it tells us little of the
magnitude of lower limb joint moments developed during these
activities.
Elderly populations have been more thoroughly investigated
already during stair walking, and have shown similarities to
diabetic populations in level walking studies, including slower
walking speeds and shorter step lengths [21] as well as decreased
muscle joint strengths [22]. Elderly people have been shown to
ascend and descent stairs with lower joint moments, but at higher
levels of their maximal joint moment-generating capabilities
[23,24]. It has been hypothesised that operating at a higher level of
their maximal capabilities may explain why the elderly have
difﬁculties completing daily activities [25,26]. If these ﬁndings
translate to a population with diabetes during stair walking, as
indications of such a trend have already been seen during level
walking [27], it may highlight the potential utility of exercise
interventions for redressing this detrimental effect of diabetes
and peripheral neuropathy and improve patients ability to
perform daily activities. Therefore, whilst strides toward asses-
sing the musculoskeletal alterations of patients with diabetes
during stair walking have begun to be addressed within the past
few years, there is still a large knowledge gap presented by the
limited number of variables reported and potential ambiguity of
the actual activities reported. This study aimed to investigate
biomechanical alterations to joint moments during stair ascent
and stair descent, as a result of the muscular joint weakness
known to occur in populations with diabetes. It was hypothesised
that patients with diabetes would adopt a strategy that reduced
peak joint moments to maintain magnitudes further within their
maximal capabilities.
2. Methods
2.1. Participants
Power analysis identiﬁed minimum group sizes of n = 18, for an
effect size 0.657 (b = 0.1, a = 1%). Power analysis was based upon
one of the key variables, ankle joint moment, conservative
population standard deviations (0.18 Nm kg1) and a between
group difference to be considered signiﬁcant (0.29 Nm kg1) based
upon previous work on stair negotiation in older adults [23,24].
After receiving ethical approval from the National Health
Service (NHS) ethics committee, as well as the relevant Hospital
and University bodies; ninety-four participants gave informed
written consent: sixty-one patients with diabetes and thirty-two
non-diabetic controls (CTRL group). Participants were assessed to
conﬁrm absence of: musculoskeletal disorders, serious foot
deformity (e.g. Charcot), open foot ulcers, lower-limb amputation,
history of cerebral injury, an inability to walk unaided, or poor
visual acuity (less than 6/18 of any aetiology). Absence of diabetes
in non-diabetic controls was conﬁrmed by a random blood glucose
test (all readings were between 4 and 7 mmol l1).
Presence of diabetic peripheral neuropathy was assessed for
using the modiﬁed Neuropathy Disability Score (mNDS) and
Vibration Perception Threshold (VPT). Patients were sub sequen-
tially assigned to either the DM group (n = 39; mNDS <6 and a VPT
<25 for both feet) or DPN group (n = 22; mNDS score 6, and/or a
VPT 25 V on either or both feet) group.2.2. Gait analysis
Participant’s gait was assessed during ascent and descent of a 7-
step staircase (Fig. 1) in a step-over-step manner (one foot per
step) at their self-selected speed. Participants were provided with
tight-ﬁtting shorts and t-shirts for the gait analysis, and
standardised footwear with a neutral foot bed (MedSurg, Darco,
Raisting, Germany) to ensure standardisation of footwear, whilst
maintaining a suitable shoe for the high-risk (ulceration) feet of the
diabetic participants. For safety, all participants wore a full-body
harness during gait analysis.
Kinematics were measured using a ten-camera Vicon (Vicon,
Oxford, UK) system, and a ﬁfty-six retroreﬂective marker modiﬁed
Helen-Hayes whole-body marker set. Modiﬁcations to the marker
set included two additional tracking markers on each foot and
shank, and three additional tracking markers on the pelvis, to
provide redundancy for any marker dropout due to occlusion by
the staircase structure. Medial ankle and knee markers were also
added to improve joint centre deﬁnition for those joints. Joint
centres were deﬁned using medial and lateral joint markers for the
ankle and knee, and hip joint centres were calculated based upon
the Bell, Pederson and Brand hip joint regression equations
[28]. Kinetics were recorded from four Kistler force platforms
(Kistler, Winterthur, Switzerland) mounted in steps 2–5 of the
seven-step staircase.
Participants were asked to ascend and descend the staircase at
their self-selected speed until a minimum of 3 trials were collected
for both ascent and descent. Adequate rest was provided between
trials to minimise the impact of fatigue. Gait velocity was
calculated for each trial and lower-limb joint moments were
calculated using inverse dynamics. Peak joint moments were
deﬁned as the peak during the stance phase.
2.3. Maximum isokinetic joint moment
Maximum effort concentric (muscle shortening) and eccentric
(muscle lengthening) ankle plantarﬂexion and knee extension
moments were measured using an isokinetic dynamometer (Cybex
Norm, USA) as previously described and performed by the same
cohort [27]. Due to patient availability, maximum isokinetic joint
moment were recorded for ﬁfty-nine (CTRL: n = 18, DM: n = 27 and
DPN: n = 14) of the original ninety-four participants. These muscle
groups were chosen as the predominant muscle groups active
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range of angular velocities (608 s1, 1208 s1, 1808 s1 and
2408 s1) to represent the range of angular velocities expected
at these joints during stair negotiation. The order of joints and
angular velocities tested was randomised for each participant, and
participants performed 3 trials of each condition from which the
peak value was selected. All performed knee extension tests in a
seated position with the hip ﬂexed at 858 (08 = supine position),
and ankle plantarﬂexion contractions whilst lying prone with the
knee in full extension.
2.4. Operating strengths
‘Operating strengths’ were deﬁned as the ratio of the peak joint
moments generated during stair ascent and descent to the
maximum isokinetic joint moment, to represent the level of each
participant’s maximal muscular ability being utilised during the
tasks. Each ratio was calculated using the result of the maximum
isokinetic joint moment measurement where conditions were
matched for muscle action (concentric or eccentric) and at the
closest joint angular velocity compared to the angular velocity at
the instant of the joint moment peak during gait.
2.5. Statistical analysis
All gait variables were assessed as a mean across the three trials
for each activity. Each trial provided four stance periods (two from
each limb) upon the force plates; resulting in a mean of twelve
values for each participant per activity to minimise the effects of
natural within-participant variability. Kinetic variables (peak joint
moments and joint work) were normalised to individual body
mass and peak joint moments were measured for the loading
(weight acceptance, 0–50% stance) and unloading (weight off-
loading, 50–100% stance) periods of stance. All variables were
analysed using a one-way analysis of variance. Due to differences
in velocity between groups, gait variables were also tested using an
analysis of covariance with velocity as the covariate. Bonferroni
post hoc tests were utilised to assess differences between groups.
3. Results
3.1. Clinical assessment
Patients in the DPN group were heavier than the CTRL and DM
groups (+24% and +18% respectively, Table 1). In line with the
selection criteria, the neuropathy measures of NDS and VPT scores
were also signiﬁcantly higher in the DPN group relative to the CTRL
and DM groups (Table 1), but no difference between CTRL and DM
groups. The DM group was also statistically similar to the CTRL
group for age, body mass, height and BMI (Table 1).Table 1
Clinical measurements for the controls (CTRL: n = 32), diabetic patients with no
neuropathy (DM: n = 39) and diabetic patients with diabetic peripheral neuropathy
(DPN: n = 22). Values are means (standard error).
Variable Group mean (standard error)
CTRL DM DPN
Age (years) 53 (3) 56 (2) 57 (2)
Body mass (kg) 75 (2) 78 (2) 93 (5)c,d
Height (m) 1.7 (0.02) 1.68 (0.02) 1.72 (0.09)
BMI (kg m2) 26 (1) 28 (1) 31 (1)c,d
NDS (Score/10) 1 (0.2) 1.6 (0.3) 7 (1)c,d
VPT (Volts) 8 (1) 10 (1) 30 (2)c,d
c Signiﬁcant (p < 0.05) difference from the controls.
d Signiﬁcant (p < 0.05) difference from the DM group.3.2. Maximum isokinetic joint moments
Maximum isokinetic joint moments were recorded for 59 of the
original 94 participants (CTRL: n = 18, DM: n = 27 and DPN: n = 14).
Both DM and DPN groups showed lower maximum isokinetic joint
moments than the CTRL group at both ankle (eccentric: 27% and
39%; concentric: 23% and 33% for DM and DPN vs. CTRLs
respectively; for 1208 s1, Table 2) and knee (eccentric: 35% and
44%; concentric: 23% and 33% for DM and DPN vs. CTRLs
respectively; for 1208 s1, Table 2). Details of maximum isokinetic
moments at all recorded joint angular velocities can be found in
supplementary Table 1.
3.3. Stair ascent
The DPN group ascended the staircase slower than either CTRLs
or DM groups, with no statistical difference between the DM and
CTRL groups.
Joint moment proﬁles for each of the three joints are shown for
ankle, knee and hip in Fig. 2. Both DM and DPN groups showed
signiﬁcantly lower peak knee joint moments than the CTRL group
(Table 3), which could not be explained by the differences in gait
velocity, with the exception of the peak knee joint moment during
loading in the DPN group.
During stair ascent there were no signiﬁcant differences in
operating strengths between the groups (Table 3).
3.4. Stair descent
The DPN group descended the staircase slower than the CTRLs,
no signiﬁcant differences in gait velocity were seen for the DM
group compared to either other group (Table 3).
Joint moment proﬁles during stair descent are shown for ankle,
knee and hip in Fig. 2. Peak knee joint moments were lower in both
DM and DPN groups compared to the CTRL group (Table 3), and
remained signiﬁcant after adjustment for velocity effects, with the
exception of loading peak in the DPN group.
During stair descent, ankle operating strengths in the DPN
group during loading and unloading were higher than those of the
CTRL group (Table 3). Knee operating strengths during unloading,
were higher in the DPN group than the CTRLs (Table 3), although
like the ankle operating strength during unloading, both only
showed signiﬁcant between group differences once adjusting for
the effects of velocity. The DM group only showed signiﬁcant
differences from the CTRL group at the ankle during loading
(Table 3).
4. Discussion
This study established a reduced muscle strength in patients
with diabetes in line with previous ﬁndings within this population
[29,30], with the most pronounced weakness in patients withTable 2
Maximum isokinetic joint moments at 1208 s1 for controls (CTRL: n = 18), diabetic
patients with no neuropathy (DM: n = 27) and diabetic patients with diabetic
peripheral neuropathy (DPN: n = 14). Values are means (standard error).
Variable Group mean (standard error)
CTRL DM DPN
Max. isokinetic joint moment (Nm kg1)
Eccentric ankle 1.49 (0.13) 1.08 (0.07)c 0.9 (0.14)c
Concentric ankle 2.44 (0.14) 1.86 (0.09)c 1.63 (0.18)c
Eccentric knee 1.65 (0.12) 1.07 (0.06)c 0.92 (0.12)c
Concentric knee 2.7 (0.15) 2.07 (0.1)c 1.79 (0.17)c
c Signiﬁcant (p < 0.05) difference from the controls.
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Fig. 2. Moment/time curves during stair ascent and stair descent. Times are normalised to stance phase (0–100%), joint moments are normalised to body mass (Nm kg1).
Solid line – non-diabetic controls (CTRL), dashed line – diabetic patients and no peripheral neuropathy (DM), dotted line – diabetic patients and peripheral neuropathy (DPN).
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knee joint moments during stair walking in patients with diabetes
both with and without neuropathy compared to healthy controls.
The differences from the controls were greatest at the knee, and in
the patients with diabetic peripheral neuropathy. Patients with
diabetes without neuropathy demonstrated signiﬁcant differences
from the controls at the knee only. However, the non-signiﬁcant
differences in this patient group were in the same direction with
those in patients with neuropathy. These ﬁndings indicate that
peripheral neuropathy has a key inﬂuence upon the differences
observed. However, the similar neuropathy scores between
patients without neuropathy and non-diabetic controls also
indicate that, as previously noted in level walking [13,31], gait
alterations are not solely a result of diabetic neuropathy.
At the ankle, signiﬁcantly lower peak joint moments were only
observed in the unloading phase of stair ascent for patients with
diabetic peripheral neuropathy compared to the non-diabetic
controls. In comparison, the knee showed signiﬁcantly lower joint
moments relative to non-diabetic controls in patients both with
and without neuropathy, during both activities. This notable
difference between ankle and knee may be associated with the
greater differences in maximal isokinetic joint moment at the knee
compared to the ankle (average differences between DPN and
CTRL: ankle 32% lower, knee 37% lower). This greater deﬁciency in
strength seen at the knee relative to the ankle is in contrast to the
distal-to-proximal progression typical of diabetic peripheral
neuropathy. It should be noted however, that diabetes itself canhave an impact upon muscle strength, independent of neuropa-
thies [30,32,33]. Whilst no signiﬁcant differences were observed at
the hip between either patient group and the non-diabetic
controls, patients without neuropathy exhibited a lower hip
extension moment during stair ascent than the patients with
neuropathy (who were similar to the non-diabetic controls). This is
the only instance within the ﬁndings of this study where the
patients without neuropathy exhibited a different manner of gait
strategy to the patients with neuropathy and is possibly a response
to the greater deﬁciencies at the knee in patients with diabetic
neuropathy. During stair ascent hip extension and knee extension
are responsible for accepting the weight of the body and lifting the
body onto the step. Given the greater strength deﬁcit at the knee in
patients with diabetic peripheral neuropathy than those without
neuropathy, patients with more advanced muscle weakness may
meet the demands of the task by increasing the workload of the hip
due to the lower magnitude of the moments required at hip
compared to the knee (e.g. hip: 0.64 Nm kg1, knee: 1.57 Nm kg1,
example taken as CTRL group during stair ascent; Table 3).
During stair descent, operating strengths were signiﬁcantly
higher for patients with diabetic peripheral neuropathy than non-
diabetic controls. These ﬁndings coincide with previous ﬁndings of
higher operating strengths in an elderly population than younger
controls during stair descent [24], despite lower peak joint
moments in the stair task. During stair ascent no differences were
seen in operating strengths between groups, indicating patients
were more capable of operating at a similar level to non-diabetic
Table 3
Gait variables during stair ascent and descent. Data shown for controls (CTRL:
n = 18), diabetic patients with no neuropathy (DM: n = 27) and diabetic patients
with diabetic peripheral neuropathy (DPN: n = 14). Values are means (standard
deviation). Covariate effects reported by the ANCOVA are indicated velocity by a
‘‘V’’. Statistical signiﬁcance between groups is shown after the means and (standard
error) in superscript: lowercase ‘‘c’’ and ‘‘d’’ denotes a signiﬁcant (p < 0.05)
difference from the CTRL and DM groups (respectively) for the ANOVA, uppercase
‘‘C’’ and ‘‘D’’ denotes a signiﬁcant (p < 0.05) difference from the CTRL and DM groups
(respectively) for the ANCOVA using gait velocity as a covariate.
Variable Covariate effects Group mean (standard error)
CTRL DM DPN
Stair ascent
Temporal spatial
Velocity (m s1) 0.48 (0.01) 0.44 (0.01) 0.39 (0.02)cd
Peak joint moments (Nm kgS1)
Ankle loading V 0.73 (0.06) 0.62 (0.04) 0.61 (0.07)
Ankle unloading V 1.28 (0.04) 1.18 (0.03) 1.12 (0.05)c
Knee loading 1.57 (0.06) 1.36 (0.04)cC 1.25 (0.06)cC
Knee unloading 0.76 (0.07) 0.57 (0.06) 0.34 (0.06)cC
Hip ﬂexion V 0.44 (0.03) 0.48 (0.03) 0.37 (0.04)
Hip extension V 0.64 (0.03) 0.56 (0.03) 0.66 (0.04)D
Operating strength (%)
Ankle loading 0.6 (0.14) 0.71 (0.1) 0.68 (0.08)
Ankle unloading V 0.91 (0.17) 1.18 (0.11) 1.45 (0.19)
Knee loading V 1.01 (0.11) 1.27 (0.14) 1.53 (0.24)
Knee unloading 0.74 (0.22) 0.62 (0.07) 0.69 (0.16)
Stair descent
Temporal spatial
Velocity (m s1) 0.53 (0.02) 0.47 (0.02) 0.42 (0.03)c
Peak joint moments (Nm kgS1)
Ankle loading V 1.07 (0.06) 1.04 (0.04) 0.94 (0.07)
Ankle unloading 1.2 (0.04) 1.14 (0.02) 1.08 (0.05)
Knee loading V 1.26 (0.05) 1.01 (0.05)cC 1 (0.07)c
Knee unloading 1.35 (0.07) 1.16 (0.03)cC 1.06 (0.05)cC
Hip ﬂexion V 0.42 (0.03) 0.36 (0.02) 0.35 (0.03)
Hip extension 0.39 (0.05) 0.27 (0.02) 0.32 (0.05)
Operating strength (%)
Ankle loading 0.65 (0.07) 1.03 (0.08)cC 1.12 (0.14)cC
Ankle unloading V 0.81 (0.06) 1.25 (0.14) 1.57 (0.25)c
Knee loading 0.89 (0.08) 1.11 (0.12) 1.42 (0.24)
Knee unloading V 0.79 (0.04) 1.13 (0.09) 1.45 (0.26)c
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operating strengths were still present (stair descent: operating
strengths average 45% higher DPN vs. CTRLs, p < 0.05; stair ascent:
operating strengths 35% higher DPN vs. CTRLs, p > 0.05). We
recently reported similar alterations in operating strengths in
patients with diabetes during level walking [27]; both during level
and stair walking patients display higher operating strengths in
spite of lower peak joint moments than controls. Higher operating
strengths during daily activities have potential implications upon
an individual’s ability to safely perform these activities.
Patients with no neuropathy have shown fewer statistical
differences from non-diabetic controls than patients with neurop-
athy for all variables. For operating strengths, only the ankle,
during stair descent, showed statistical difference between
patients without neuropathy and non-diabetic controls. Whilst
there were consistent trends of lower joint moments, lower
maximal isokinetic joint moments, and higher operating strengths
in both patient groups compared to non-diabetic controls; the
extent of the differences is lesser within the patients without
neuropathy. This indicates that differences in walking strategy on
stairs in patients with diabetes is caused by multiple factors, rather
than neuropathy alone. However, without the presence of
neuropathy, alterations to walking strategy are less pronounced.
In the present study the patients with diabetic peripheral
neuropathy, demonstrated a slower gait velocity during both stair
ascent and stair descent than non-diabetic controls. During levelwalking, slower walking speeds are known to reduce joint
moments [34]; therefore the impact of velocity as a covariate
was assessed. During stair descent, the group effects were seen in
ankle and knee operating strengths during unloading. However, a
slower gait velocity and the associated lower joint moments
should create an expectation of lower rather than higher operating
strengths. The opposite presented here, indicating a relationship
with the maximum isokinetic joint moments and slower gait
velocity, is in line with ﬁndings of level walking [34] where self-
selected walking speed correlated with lower-limb joint strength.
Velocity effects can be seen on a number of the variables assessed
here, highlighting the importance of slower speeds as a coping
mechanism in patients with diabetes, however, some of the
changes to gait strategy showed no velocity effect, indicating
strategies other than just walking slower are being utilised in order
to lower joint moments.
4.1. Limitations
Although joint moments were normalised to body mass, it
should be noted that the DPN group was heavier, with a higher BMI
than the DM and CTRL groups, and these variables have been
previously shown to be associated with lower gait velocity
[35,36]. However, when walking at standardised speeds, extremes
in body mass have been shown to produce comparable joint
moments during level walking [37]. Whilst the vertical motion of
stair walking may suggest a need for higher joint moments in
heavier individuals not necessarily present during level walking,
the results presented here show lower joint moments in the
heavier group. Therefore, we may remain conﬁdent in the between
group differences shown, as whilst variables may be inﬂuenced by
weight, the differences seen here cannot be explained by body
mass differences alone.
5. Conclusion
We have demonstrated that patients with diabetes and
particularly patients with diabetic peripheral neuropathy, exhibit
lower lower-limb muscular capabilities and ascend and descent
stairs more slowly than healthy controls. We have also shown that
patients with neuropathy alter gait strategy to lower peak knee
joint moments, which cannot be fully explained by the slower gait
velocity adopted. Despite this however, during stair descent
patients with diabetic peripheral neuropathy still operate at a
higher level of their maximal joint moment-generating capabilities
at the knee, which may have implications for adequately
responding to perturbations in balance.
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